Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin
Open Access
- 21 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (7), 2390-2397
- https://doi.org/10.1021/acs.molpharmaceut.0c00151
Abstract
Opticin is an endogenous vitreous glycoprotein that may have therapeutic potential as it has been shown that supra-normal concentrations supress preretinal neovascularisation. Herein we investigated the pharmacokinetics of opticin following intravitreal injection in rabbits. To measure simultaneously concentrations of human and rabbit opticin, a selected reaction monitoring mass spectrometry assay was developed. The mean concentration of endogenous rabbit opticin in 7 uninjected eyes was measured and found to be 19.2 nM or 0.62 µg/ml. When the vitreous was separated by centrifugation into a supernatant and collagen-containing pellet, 94 % of the rabbit opticin was in the supernatant. Intravitreal injection of human opticin (40 µg) into both eyes of rabbits was followed by enucleation at 5 h, 24 h, 72 h, 7 days, 14 days and 28 days post-injection (n=6 at each time point) and measurement of vitreous human and rabbit opticin concentrations in the supernatant and collagen-containing pellet following centrifugation. The volume of distribution of human opticin was calculated to be 3.31 ml and the vitreous half-life 4.2 days. Assuming that rabbit and human opticin are cleared from rabbit vitreous at the same rate, opticin is secreted into the vitreous at a rate of 0.14 µg/day. We conclude that intravitreally injected opticin has a vitreous half-life that is similar to currently available anti-angiogenic therapeutics. Whilst opticin was first identified bound to vitreous collagen fibrils, here we demonstrate that >90% of endogenous opticin is not bound to collagen. Endogenous opticin is secreted by the non-pigmented ciliary epithelium into the rabbit vitreous at a remarkably high rate and the turnover in vitreous is approximately 15% per day.Keywords
Funding Information
- Medical Research Council (MR/M025365/1)
- National Institute for Health Research
- H2020 Marie Sklodowska-Curie Actions (799880)
This publication has 22 references indexed in Scilit:
- Mapping the Differential Distribution of Proteoglycan Core Proteins in the Adult Human Retina, Choroid, and ScleraInvestigative Ophthalmology & Visual Science, 2012
- Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CTCurrent Eye Research, 2012
- Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix AdhesivenessOnline Journal of Public Health Informatics, 2012
- The Vitreous Glycoprotein Opticin Inhibits Preretinal NeovascularizationInvestigative Ophthalmology & Visual Science, 2012
- Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)Ophthalmology, 2007
- The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modificationsMethods, 2005
- Immunolocalisation of opticin in the human eyeBritish Journal of Ophthalmology, 2004
- Characterization of Opticin and Evidence of Stable Dimerization in SolutionOnline Journal of Public Health Informatics, 2003
- The role of the posterior ciliary body in the biosynthesis of vitreous humourEye, 2002
- Elaboration of Bicarbonate Ion in Intraocular FluidsA.M.A. Archives of Ophthalmology, 1957